Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRay GroupSHSE:688301 -2.07%95 Quick Ratio is 2.87 as of Jun. 2026, which is 32% below its 10-year median of 4.23. GuruFocus rates SHSE:688301 with a GF Score™ of 95/100 and a GF Value™ of ¥109.99 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 849 Medical Devices & Instruments companies, iRay Group ranks better than 67.73% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. iRay Group's quick ratio for the quarter that ended in Jun. 2026 was 2.87.
iRay Group has a quick ratio of 2.87. It generally indicates good short-term financial strength.
The historical rank and industry rank for iRay Group's Quick Ratio or its related term are showing as below:
SHSE:688301'
s Quick Ratio Range Over the Past 10 Years
Min: 1.65 Med: 4.23 Max: 12.79
Current: 2.87
During the past 11 years, iRay Group's highest Quick Ratio was 12.79. The lowest was 1.65. And the median was 4.23.
SHSE:688301's Quick Ratio is ranked better than 67.73% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 1.83
vs SHSE:688301: 2.87
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
iRay Group Quick Ratio Related Terms
iRay Group Quick Ratio Historical Data
* Premium members only.
The historical data trend for iRay Group's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688301 vs ISRG, BDX, RMD: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, iRay Group's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRay Group Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRay Group's Quick Ratio distribution charts can be found below:
* The bar in red indicates where iRay Group's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
iRay Group's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRay Group (SHSE:688301) has a Quick Ratio of 2.87 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on iRay Group and its competitors. This is 32% below median its historical median of 4.23. Over the past decade, iRay Group's Quick Ratio has ranged from 1.65 to 12.79. According to the industry distribution chart, iRay Group ranks #274 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 32.3%.
Is iRay Group's Quick Ratio too high?
iRay Group's current Quick Ratio of 2.87 is 32% below median its 10-year median of 4.23. Over the past 10 years, this metric has ranged from a low of 1.65 to a high of 12.79. The Medical Devices & Instruments industry median Quick Ratio is 1.83. iRay Group's value of 2.87 is 56.8% above this industry median. Based on the distribution chart, iRay Group ranks #274 out of 849 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, iRay Group has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRay Group's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iRay Group ranks #274 out of 849 companies for Quick Ratio. This puts iRay Group in the upper half of its industry. The industry median Quick Ratio is 1.83. iRay Group's value of 2.87 is 56.8% above this benchmark. Historically, iRay Group's own Quick Ratio has ranged from 1.65 to 12.79 over the past decade. While the company's 10-year median is 4.23 vs. the industry median of 1.83, iRay Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.83, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRay Group's current Quick Ratio of 2.87 is 56.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on iRay Group and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRay Group's current Quick Ratio is 2.87, which is 32% below median its own 10-year median of 4.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRay Group stock overvalued right now?
Based on GuruFocus' analysis, iRay Group (SHSE:688301) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥109.99, compared to a current price of ¥88.54 — trading 19.5% below its estimated fair value. The current Quick Ratio is 2.87, which is 32% below median its 10-year median of 4.23 and 56.8% above the Medical Devices & Instruments industry median of 1.83. iRay Group's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For iRay Group (SHSE:688301), the current Quick Ratio is 2.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRay Group (SHSE:688301) Overvalued in 2026?
Based on GuruFocus' analysis, iRay Group stock appears to be undervalued.
The current stock price of ¥88.54 is trading 19.5% below its estimated GF Value™ of ¥109.99.
GuruFocus considers iRay Group to be Modestly Undervalued.
Key valuation signals for SHSE:688301:
Quick Ratio: 2.87 (32% below median its 10-year median of 4.23)
GF Value™: ¥109.99 vs. price of ¥88.54 (19.5% below fair value)
Industry Position: 56.8% above the Medical Devices & Instruments median (#274 of 849)
No single metric tells the full story. See the SHSE:688301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688301 has been successfully added to your 
